Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice

J Pharm Pharmacol. 2005 Aug;57(8):1043-52. doi: 10.1211/0022357056523.

Abstract

We have investigated the protective effects of grape seed proanthocyanidins on doxorubicin-induced toxicity in tumour-bearing mice. The intraperitoneal administration of doxorubicin (2 mg kg(-1) every other day, cumulative dosage for 18 mg kg(-1)) significantly inhibited the growth of sarcoma 180, and induced myocardial oxidative stress with decreased superoxide dismutase and glutathione peroxidase activity while increasing malondialdehyde formation in the heart or serum. Doxorubicin-induced myocardial oxidative stress also reduced lactate dehydrogenase and creatine kinase activity in the heart and elevated their levels in the serum. Doxorubicin also affected immune functions of tumour-bearing mice with significantly decreased interleukin-2 (IL-2) and interferon-gamma (INF-gamma) production, and slightly decreased natural killer (NK) cell cytotoxicity, lymphocyte proliferation and CD4+/CD8+ ratio. It markedly increased the percentages of cytotoxic T cells (CD3+CD8+), helper T cells (CD3+CD4+), IL-2R+CD4+, and IL-2R+ cells as compared with untreated tumour-bearing mice. The intragastric administration of proanthocyanidin (200 mg kg(-1) daily) significantly inhibited tumour growth, and increased NK cell cytotoxicity, lymphocyte proliferation, CD4+/CD8+ ratio, IL-2 and INF-gamma production. Moreover, proanthocyanidin strongly enhanced the anti-tumour effect of doxorubicin and the above immune responses, and completely eliminated myocardial oxidative stress induced by doxorubicin. In conclusion, intragastric administration of proanthocyanidin could enhance the anti-tumour activity of doxorubicin and ameliorate doxorubicin-induced myocardial oxidative stress and immunosuppression in tumour-bearing mice.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacology*
  • Antibiotics, Antineoplastic / therapeutic use
  • Antibiotics, Antineoplastic / toxicity
  • Antigens, CD / analysis
  • Antineoplastic Agents / pharmacology*
  • Cytokines / biosynthesis
  • Cytokines / drug effects
  • Doxorubicin / pharmacology*
  • Doxorubicin / therapeutic use
  • Doxorubicin / toxicity
  • Drug Interactions*
  • Female
  • Heart / drug effects
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use
  • Immunosuppressive Agents / toxicity
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation / drug effects
  • Lymphocyte Subsets / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Myocardium / enzymology
  • Myocardium / metabolism
  • Oxidative Stress / drug effects
  • Proanthocyanidins / isolation & purification
  • Proanthocyanidins / pharmacology*
  • Receptors, Interleukin-2 / analysis
  • Sarcoma 180 / drug therapy*
  • Seeds
  • Vitis* / chemistry

Substances

  • Antibiotics, Antineoplastic
  • Antigens, CD
  • Antineoplastic Agents
  • Cytokines
  • Immunosuppressive Agents
  • Proanthocyanidins
  • Receptors, Interleukin-2
  • proanthocyanidin
  • Doxorubicin